Dispensary Purchase Limits: State-by-State Rules
Purchase limits at dispensaries are not suggestions — they are statutory caps encoded in state law, tracked in real time through seed-to-sale systems, and enforced with consequences that run from license suspension to criminal referral. This page breaks down how those limits are structured, what drives the variation between states, and how the rules shift depending on whether a purchase is medical or recreational.
Definition and scope
A dispensary purchase limit is the maximum quantity of cannabis or cannabis-equivalent product a single customer may legally acquire within a defined rolling window — usually one day, sometimes three, occasionally seven. The limits apply at the point of sale and are enforced through state-mandated tracking systems like METRC (Marijuana Enforcement Tracking Reporting Compliance), which logs every transaction at licensed dispensaries in participating states.
The scope of what counts toward the limit is where things get genuinely complicated. States measure in different units — some use flower weight in ounces, others use total THC milligrams, and a handful require proportional equivalency calculations across product types. Colorado, for example, allows adults to purchase 1 ounce of flower per day (Colorado MED, C.R.S. § 44-10-203), but concentrates and edibles count against that total using defined conversion ratios. California sets its adult-use limit at 28.5 grams of non-concentrated cannabis plus 8 grams of concentrate, tracked separately (California BCC, Business and Professions Code § 26070).
Medical patients operate under a parallel — and often more generous — framework. States that distinguish medical from recreational purchase limits typically allow registered patients to possess and purchase higher quantities, sometimes by a factor of two or more, in recognition of therapeutic dosing needs. The dispensary regulatory context shapes how those patient-tier limits are administered at the state level.
How it works
At the point of sale, a budtender inputs the transaction into the dispensary's point-of-sale system, which is integrated with the state's compliance platform. METRC and similar systems — including BioTrackTHC, used in states like Florida — cross-reference the customer's ID against that day's purchase history statewide, not just at that location. A patient who has already hit their daily limit at one dispensary cannot legally complete a second purchase at another.
The mechanism works in discrete layers:
- Customer identification — government-issued ID (adult-use) or medical card with registry verification (medical patients)
- Historical purchase check — the compliance system queries existing transactions tied to that ID for the rolling window period
- Product weight equivalency calculation — concentrates, edibles, and flower are converted to a common unit; the math varies by state
- Transaction approval or flag — the system approves, partially approves (up to the remaining limit), or blocks the sale
- Recordkeeping — the completed transaction is logged in the state system, updating the patient or consumer's rolling total
Dispensaries that bypass or fail this process face regulatory action under their state's cannabis control authority — in California, that's the Department of Cannabis Control (DCC); in Michigan, it's the Cannabis Regulatory Agency (CRA).
Common scenarios
Medical patient purchasing flower and edibles in Illinois: Illinois sets a 2.5-ounce-per-14-day limit for registered medical patients (Illinois Department of Public Health, 410 ILCS 130). Edibles count against that limit using THC-equivalency conversions rather than raw weight, which means a patient buying a high-potency edible product may exhaust their limit faster than a patient buying low-potency flower.
Adult-use customer in Nevada: Nevada permits 1 ounce of flower per day for recreational purchasers (Nevada Cannabis Compliance Board, NRS Chapter 678C). Concentrates are capped separately at 3.5 grams per transaction, making Nevada one of the states that tracks concentrate limits as a distinct category rather than a flower-equivalent conversion.
Out-of-state visitor in a reciprocity state: A handful of states — including New Mexico and Arizona — extend reciprocal recognition to medical cards from other states under specific conditions. Even with reciprocity, purchase limits follow the host state's rules, not the patient's home state. The specifics of that framework are covered in detail on the dispensary reciprocity laws page.
First-time recreational purchaser hitting an unexpected cap: Some states impose stricter caps on the first year of adult-use sales. New York, as its market matures under the Office of Cannabis Management (OCM), has issued guidance on limits tied to specific license classes — an evolving target that tracks with market development.
Decision boundaries
The clearest dividing line in purchase limit structures is medical versus recreational. Medical limits are almost uniformly higher and are often tied to a physician's recommendation or a specific qualifying condition. Recreational limits prioritize diversion prevention over therapeutic access, which is why they tend to be stricter.
The second meaningful distinction is product type classification. States fall into two camps: those that use a unified flower-equivalent weight (adding concentrates and edibles back into a single ounce figure using set multipliers), and those that maintain separate category limits. The unified model is simpler to enforce; the separate-category model creates space for patients and consumers to purchase across product types without one exhausting the other.
A useful reference for the full national landscape — including which states operate medical-only markets, dual-use markets, or have no licensed dispensary framework at all — is the dispensary homepage, which maps the regulatory environment across all 50 states. Compliance with purchase limits is also one dimension of the broader dispensary compliance requirements that operators must maintain to retain licensure.
Where state law is silent on a specific product category — CBD-dominant products below the federal 0.3% THC threshold, for instance — federal framework under the 2018 Farm Bill (7 U.S.C. § 1639o) may govern instead, though state regulators sometimes assert concurrent jurisdiction.